Skip to main content
Log in

Genetic Markers for Cardiovascular Disease in Psoriasis: The Missing Piece

  • Short Communication
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

Abstract

Psoriasis is a common, chronic inflammatory disease associated with serious comorbidities. Severe psoriasis has been associated with increase cardiovascular mortality, due to a higher prevalence of traditional cardiovascular risk factors such as diabetes, hypertension, dyslipidemia and obesity, and premature atherosclerosis, as a consequence of its systemic inflammation. It is likely that there are genetic links between psoriasis, its comorbidities and cardiovascular disease. Although there are some studies performed in rheumatoid arthritis reporting some gene polymorphisms that may be associated with cardiovascular diseases and comorbidities these studies are lacking in psoriasis. Recognizing genetic markers that could predict which patients are at risk of developing psoriasis-linked cardiovascular comorbidities would facilitate screening strategies and permit an earlier management of cardiovascular risk factors, with important clinical implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352:1899–912.

    Article  PubMed  Google Scholar 

  2. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.

    Article  CAS  PubMed  Google Scholar 

  3. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–41.

    Article  CAS  PubMed  Google Scholar 

  4. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129:2411–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Abuabara K, Azfar RS, Shin DB, et al. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK. Br J Dermatol. 2010;163:586–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Gulliver WP, Macdonald D, Gladney N, et al. Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population. J Cutan Med Surg. 2011;15:37–47.

    PubMed  Google Scholar 

  7. Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost. 2009;35:313–24.

    Article  CAS  PubMed  Google Scholar 

  8. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31:1000–6.

    Article  PubMed  Google Scholar 

  9. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–19.

    Article  CAS  PubMed  Google Scholar 

  10. Chiricozzi A, Zhang S, Dattola A, et al. New insights in the pathogenesis of cutaneous autoimmune disorders. J Biol Regul Homeost Agents. 2012;26:165–70.

    CAS  PubMed  Google Scholar 

  11. Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130:1785–96.

    Article  CAS  PubMed  Google Scholar 

  12. Kimball AB, Guérin A, Tsaneva M, et al. Economic burden of comorbidities in patients with psoriasis is substantial. J Eur Acad Dermatol Venereol. 2011;25:157–63.

    Article  CAS  PubMed  Google Scholar 

  13. Siegel D, Devaraj S, Mitra A, et al. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol. 2013;44:194–204.

    Article  CAS  PubMed  Google Scholar 

  14. Gerdes S, Rostami-Yazdi M, Mrowietz U. Adipokines and psoriasis. Exp Dermatol. 2011;20:81–7.

    Article  CAS  PubMed  Google Scholar 

  15. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013;31:433–42.

    Article  CAS  PubMed  Google Scholar 

  16. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012;2:e54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Elahi MM, Asotra K, Matata BM, et al. Tumor necrosis factor alpha −308gene locus promoter polymorphism: analysis of association with health and disease. Biochim Biophys Acta. 2009;1792:163–72.

    Article  CAS  PubMed  Google Scholar 

  18. Abraham LJ, Kroeger KM. Impact of the −308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999;66:562–6.

    CAS  PubMed  Google Scholar 

  19. Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, et al. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis. 2011;216:125–30.

    Article  PubMed  Google Scholar 

  20. Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2009;27:964–70.

    CAS  PubMed  Google Scholar 

  21. Panoulas VF, Douglas KM, Smith JP, et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium. 2008;15:203–12.

    Article  CAS  PubMed  Google Scholar 

  22. Toms TE, Smith JP, Panoulas VF, et al. Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis. J Rheumatol. 2012;39:218–25.

    Article  CAS  PubMed  Google Scholar 

  23. Abdel Hay RM, Rashed LA. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis. Exp Dermatol. 2011;20:715–9.

    Google Scholar 

  24. Tian S, Krueger JG, Li K, et al. Meta-analysis derived (MAD) transcriptome of psoriasis defines the “core” pathogenesis of disease. PLoS One. 2012;7:e44274.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Lu Y, Chen H, Nikamo P, et al. Association of cardiovascular and metabolic disease genes with psoriasis. J Invest Dermatol. 2013;133:836–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199–204.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4:e1000041.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to prepare this manuscript.

Conflict of interest

The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tiago Torres.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torres, T., Chiricozzi, A., Chimenti, S. et al. Genetic Markers for Cardiovascular Disease in Psoriasis: The Missing Piece. Mol Diagn Ther 18, 93–95 (2014). https://doi.org/10.1007/s40291-013-0056-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40291-013-0056-1

Keywords

Navigation